Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
Cash from Financing Activities
Shin Nippon Biomedical Laboratories Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Cash from Financing Activities
¥2.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
CMIC Holdings Co Ltd
TSE:2309
|
Cash from Financing Activities
-¥1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
Medinet Co Ltd
TSE:2370
|
Cash from Financing Activities
¥1.2B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-12%
|
|
CellSource Co Ltd
TSE:4880
|
Cash from Financing Activities
¥1.4B
|
CAGR 3-Years
112%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Cash from Financing Activities
-¥1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-18%
|
|
WDB coco Co Ltd
TSE:7079
|
Cash from Financing Activities
-¥101.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Cash from Financing Activities?
Cash from Financing Activities
2.1B
JPY
Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Cash from Financing Activities amounts to 2.1B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-3%
Over the last year, the Cash from Financing Activities growth was -50%.